title: Neuron-specific enolase and thymidine kinase as an aid to the diagnosis and treatment monitoring of small cell lung cancer.
abstract: The serum levels of neuron specific enolase (s-NSE) and thymidine kinase (s-TK) were studied in detail in patients with small cell lung cancer (SCLC) to evaluate as to whether their combined use may aid to diagnosis and follow-up of this particular tumor. Only s-NSE could differentiate between SCLC and non-small cell lung cancer (NSCLC) or benign pulmonary diseases (BPD) to some extent, pathologic serum concentrations occurring in 81%, 17%, and 0%, respectively. The comparable figures for s-TK were 62%, 24%, and 28%, respectively. Serum NSE decreased and increased paralleling tumor regression and progression, respectively, except when brain metastases were present. Alterations of s-TK, in contrast, did not usually mirror the course of disease. During initial chemotherapy (CT) a transitory increase of serum levels was observed for both NSE and TK. Monitoring, based on daily blood samples, showed comparable peaks only for s-TK during the following CT cycles, whereas s-NSE was within the normal range even when tumor mass was still present. Those subsequent s-TK peaks under CT may be due to tumor cell lysis as a result of CT indicating the efficacy of treatment by this way. Rapidly proliferating tissues such as bone marrow or bowel mucosa, however, have also to be considered as possible sources of s-TK.
authors.affiliation: Medizinische Poliklinik, University of Würzburg, Federal Republic of Germany.
authors.forename: W
authors.initials: W
authors.lastname: Fischbach
authors.forename: C
authors.initials: C
authors.lastname: Schwarz-Wallrauch
authors.forename: B
authors.initials: B
authors.lastname: Jany
mesh_terms: D000368:Aged; D018288:Carcinoma, Small Cell / Q000175:diagnosis / Q000201:enzymology* / Q000556:secondary / Q000628:therapy; D004796:Clinical Enzyme Tests; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000201:enzymology* / Q000628:therapy; D008297:Male; D008479:Mediastinal Neoplasms / Q000201:enzymology / Q000556:secondary; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000201:enzymology; D010751:Phosphopyruvate Hydratase / Q000097:blood*; D013937:Thymidine Kinase / Q000097:blood*
chemical_list: D013937:Thymidine Kinase; D010751:Phosphopyruvate Hydratase